Cryo-Cell International Other Current Liabilities

As of the most recent data (May 2026), CCEL shows a other current liabilities of $3M. That compares with $5.1M in the prior-year period — down 41.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CCEL's other current liabilities is now $3M (was $5.1M) — a 41.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cryo-Cell International is outperforming or lagging.

Tracking CCEL's other current liabilities over time shows whether Cryo-Cell International is scaling, shrinking, or reshaping that part of the business. The current reading is $3M That compares with $5.1M in the prior-year period — down 41.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Cryo-Cell International's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $3M) with ownership activity and broader fundamentals.

Cryo-Cell International's other current liabilities is $3M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.